2m 2m 2m 2m 2m 2m 2m
AYTU BIOPHARMA (AYTU)
NASDAQ
$2.28+$0.05 (+2.24%)
Price as of Aug 03, 2026 12:29 PM EDT- $23.9MMarket Cap
- -7.08%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AYTU BIOPHARMA (AYTU)
$2.28+$0.05 (+2.24%)
AYTU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.23 | ||
Change | +$0.08 (+3.72%) | ||
Open | $2.16 | ||
High | $2.25 | ||
Low | $2.13 | ||
Previous Close | $2.15 | ||
Volume | 73,171 | ||
30-Day Average Volume | 24,294 | ||
1-Week Change | 3.24% | ||
1-Month Change | 3.72% | ||
1-Year Change | -7.08% | ||
3-Year Change | 23.20% | ||
5-Year Change | -97.19% | ||
Fundamentals | |||
Shares Outstanding | 10.7M | ||
Total Assets | $111.7M | ||
Market Cap | $23.9M | ||
Enterprise Value | $19.0M | ||
Period: QTR TTM FY | |||
Revenue | $12.4M | ||
Net Income | -$5.6M | ||
Free Cash Flow | -$4.2M | ||
EBIT | -$5.5M | ||
EBITDA | -$4.4M | ||
Net Working Capital | $7.4M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 01/06/2023 | ||